hzVSF-v13

· ImmuneMed, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for hzVSF-v13, covering 2021-04-02 to 2024-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia [Phase 2]